Browsing publications by Dr Tina Biss

Newcastle AuthorsTitleYearFull text
Salah Abohelaika
Dr Tina Biss
Dr Hilary Wynne
Professor Farhad Kamali
C0170: The Impact of Dietary Vitamin K on the Pharmacological Activity of FXa Inhibitor Rivaroxaban in Man2014
Dr Tina Biss
Professor Farhad Kamali
Characterizing variability in warfarin dose requirements in children using modelling and simulation2014
Dr Tina Biss
Bruce Jaffray
Risk Stratification for the Use of Thromboprophylaxis in Young People With IBD Requires Further Evaluation2014
Salah Abohelaika
Dr Tina Biss
Dr Peter Murphy
Professor Farhad Kamali
The impact of dietary vitamin K on the pharmacological activity of FXa inhibitor rivaroxaban in man2014
Dr Tina Biss
Dr Peter Avery
Julian Leathart
Professor Farhad Kamali
VKORC1 and CYP2C9 genotype is associated with over-anticoagulation during initiation of warfarin therapy in children2012
Dr Tina Biss
Dr Peter Avery
Professor Farhad Kamali
Warfarin dose prediction in children using pharmacogenetics information2012
Dr Tina Biss
Dr Peter Avery
Julian Leathart
Professor Farhad Kamali
Warfarin dose prediction in children using pharmacogenetics information2012
Dr Tina Biss
Dr Peter Avery
Julian Leathart
Dr John Hanley
Professor Ann Daly
et al.
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children2011
Dr Tina Biss
-1 to+4 vs. 0 to+3?: comparing scoring systems for bleeding symptoms in the condensed mcmdm-1 VWD and the pediatric bleeding questionnaires2011
Dr Tina Biss
Dr Peter Avery
Professor Farhad Kamali
Comparison of 'time within therapeutic INR range' with 'percentage INR within therapeutic range' for assessing long-term anticoagulation control in children2011
123